Market news

Hostile takeovers are called hostile for a reason, and this one is getting ugly.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis gains momentum as international medical cannabis growth lifts earnings estimates, while Baidu faces pressure from weakness in its core business.

Sector is urging the government to back efforts to develop global markets as it forecasts $2-billion in foreign sales in 2027

Detailed price information for Aurora Cannabis Inc (ACB-T) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis reforms.

Curaleaf Holdings (USOTC:CURLF) has sent a letter to Aurora Cannabis (NASDAQ:ACB) shareholders urging them to tender their shares to its outstanding acquisition offer after Aurora’s board declined to engage with the proposal. Under the offer, Aurora shareholders would receive 0.

Curaleaf is asking Alberta regulators to halt Aurora’s share sales, arguing the company shouldn’t be diluting shareholders at $3.04 while rejecting a $4 takeover offer.

Detailed price information for Aurora Cannabis Inc (ACB-T) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-T) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-T) from The Globe and Mail including charting and trades.

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the leading Canadian-based global medical cannabis company, today urged shareholders to reject the unsolicited take-over bid ("Hostile Bid") from Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF), warning that the Hostile Bid would put Aurora shareholders' value and future upside at risk. Following a comprehensive review by Aurora's Board of Directors (the "Board"), on the unanimous recommendation of a speci

Aurora Cannabis (ACB) said Wednesday its board unanimously advised shareholders to reject an unsolic

Aurora Cannabis (ACB.TO) urged shareholders to reject Curaleaf Holdings (CURA.TO)'s unsolicited take

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today responded to misleading statements contained in Aurora Cannabis Inc.'s (TSX: ACB) (NASDAQ: ACB) ("Aurora") Directors' Circular and reiterated its belief that the Curaleaf offer represents the most compelling path forward for Aurora shareholders.

Like Logan Roy on HBO, Aurora CEO Miguel Martin is fending off a bear hug. We’ll see if a deal gets done.

In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.

Aurora said its Board, along with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal as it determines the future course of action.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Green Thumb Industries is in a strong position to acquire other cannabis companies, but will that happen?

After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.